NEOGAP Therapeutics AB
Kelly D. is a Senior Scientist at NEOGAP Therapeutics AB since April 2022, with additional experience as a Bioengineer at Anocca AB since January 2019. Previously, Kelly has held positions as a Laboratory Engineer at Karolinska Institutet from April 2012, following a similar role at the same institution from 2010 to 2012. Early career experience includes work as an Occupational Therapy Assistant at the Royal Hospital for Neuro-disability from September 2008 to June 2010. Kelly D. holds a Bachelor's Degree in Biology and Psychology from the University of Roehampton, completed in 2007.
This person is not in any offices
NEOGAP Therapeutics AB
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.